Please select the option that best describes you:

How would you approach a patient with recurrent grade 3 oligodendroglioma (MGMT-methylated, IDH mutant, 1p/19q co-deleted) 1 year after gross total resection and adjuvant chemotherapy and radiation?  

How would this differ if a new area of disease were outside prior radiation fields?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more